Jill F. Schiaparelli

Jill joined the InteloMed Board of Directors in April 2015 and served as President and CEO from July 2015 until May 2017. Jill has more than 20 years of global experience in health care innovation, strategy and commercialization.

She has launched multiple medical device and biotech products and has held senior leadership positions with major healthcare companies such as Johnson & Johnson and Baxter and has served as an executive at high-growth biotech companies such as ApaTech (UK) (sold to Baxter) and AxoGen.

Jill currently serves as the President and CEO of Avation Medical, a venture-backed medical technology company making neuromodulation more accessible to patients as a treatment for a wide variety of clinical conditions. Jill is also a founding partner in JS Strategic Partners, a strategic consulting group to help young companies bring innovative technologies to market. Her early career was spent in investment banking and finance.

Jill received her MBA from the Stern School of Business at New York University and a Bachelor of Science in Business Administration from Boston University.